ANCA-associated Vasculitis - 103 Studies Found
| Completed |
: Educational Needs of Patients With Systemic Vasculitis :
|
| Completed |
: Vasculitis Illness Perception (VIP) Study :
|
| Completed |
: Reproductive Health in Men and Women With Vasculitis :
|
| Completed |
: A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis : Wegener's Granulomatosis or Microscopic Polyangiitis : 2014-04-14 :
|
| Completed |
: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases :
|
| Active, not recruiting |
: A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis : Granulomatosis With Polyangiitis : 2012-12-13 : Drug: Rituximab Participants will receive rituximab 375 mg/m^2 IV infusion on Days 1, 8, 15 and 22. Ritu |
| Completed |
: Belimumab in Remission of VASculitis : Vasculitis : 2012-08-09 :
|
| Active, not recruiting |
: An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis :
: 2012-06-04 : Drug: Rituximab Participants received rituximab at the discretion of their treating physicians. |
| Terminated |
: Plasma Exchange for Renal Vasculitis :
: 2011-08-02 :
|
| Terminated |
: Alemtuzumab for ANCA Associated Refractory Vasculitis :
|